Elocta was associated with better bleed control and fewer injections for hemophilia A patients in a real-world European study ...

The FDA has approved Hympavzi to prevent bleeding episodes in hemophilia A and B patients aged 12 and older. This innovative ...

Haemophilia is a rare bleeding disorder affecting less than 0.01 per cent of Malaysians, requiring daily medical ...

The increased RM25 million allocation in the 2025 Budget for rare disease treatment costs is expected to improve haemophilia ...

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein ...

Generated $196.8 million in 3Q 2024 revenues, including $176.6 million in U.S. net product salesGrew SYFOVRE® (pegcetacoplan injection) demand by ...

Risk factors: diabetes, renal failure ... by placing a detachable loop ligating device or utilizing submucosal injection. The resection of small polyps (<1 cm) is probably safe in patients ...

The gene therapy improved annualized bleed rates, though a handful of study participants resumed factor IX prophylaxis.

The first time I saw ovaries was in a middle school health class. The gym teacher awkwardly pointed at a diagram on a ...

After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the ...

Columnist Joe MacDonald recalls having bronchitis yet having no other choice than to continue his son's factor infusion.